Meet Lophius at the 45th annual meeting of the EBMT

Meet Lophius at the 45th annual meeting of the European Society for Blood and Marrow Transplantation (EBMT) in Frankfurt, March 24 - 27, 2019.

Lophius recently announced successful top-line results from its multicenter AlloProtect CMV clinical study in hematopoietic stem cell transplant recipients.

We would like to invite you now to the scientific talk of Dr. Eva Wagner-Drouet (Mainz, Germany) about the soon-to-be published AlloProtect CMV study results.

The oral presentation OS6-6 is part of the session "Oral Session 6 - Infectious diseases" held in "Conclusio 1+2" on March 26^th, 02:55-03:06 pm.
Title of the talk: "Clinical validation of a novel ELISpot-based in vitro diagnostic assay: Monitoring cytomegalovirus-specific cell-mediated immunity and risk stratification in hematopoietic stem cell transplant recipient"

Interested to learn more about the capabilities of our CE-marked T-Track^® CMV test in the field of hematopoietic stem cell transplantation?
You are welcome to meet Dr. Katharina Eder and Dr. Traudel Schmidt at booth B41 at the industry exhibition.

Back